In addition, a WNT pathway inhibitor combined with anti-PD-L1 antibodies facilitated T cell infiltration and provoked strong antitumor immunity and tumor regression in the MC38/shAscl2 mouse CRC model. Here, CD274 is linked to neoplasm.